Novo Nordisk A/S NONOF
COM · Common Stock · CUSIP K72807140
- SectorHealth care
- IndustryPharmaceutical Preparations
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $154.11.
Trends to Q1 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2023 | 2 |
| Q4 2023 | 2 |
| Q1 2024 | 3 |
| Q2 2024 | 3 |
| Q3 2024 | 2 |
| Q4 2024 | 3 |
| Q1 2025 | 2 |
| Q2 2025 | 3 |
| Q3 2025 | 3 |
| Q4 2025 | 2 |
| Q1 2026 | 3 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2024 | 1 | 0 |
| Q3 2024 | 0 | 1 |
| Q4 2024 | 2 | 0 |
| Q1 2025 | 0 | 2 |
| Q2 2025 | 1 | 0 |
| Q3 2025 | 2 | 1 |
| Q4 2025 | 0 | 2 |
| Q1 2026 | 2 | 1 |
Biggest buyers
| Cygnus Capital Advisors, LLC | New | +54.8k |
| Generali Investments CEE, investicni spolecnost, a.s. | New | +30.3k |
Biggest sellers
| Steigerwald, Gordon & Koch Inc. | Sold out | -60 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| BlackRock, Inc. 13G · institution filed 2025-04-23 | 5.2% |
Insider purchases and sales in Q1 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q1 2026.
Holders, Q1 2026
| Manager | Shares | Change |
|---|---|---|
| Cygnus Capital Advisors, LLC 8.65% of their portfolio | 54.8k $12.7m | New |
| Generali Investments CEE, investicni spolecnost, a.s. 0.06% of their portfolio | 30.3k $1.1m | New |
| ATLAS CAPITAL ADVISORS INC. 0.02% of their portfolio | 5.2k $186.3k | Unchanged |